搜索临床试验以:ABI-009
总计6153个结果
-
University of AarhusOdense University Hospital; Oslo University Hospital; Rigshospitalet, Denmark; Hvidovre University... 和其他合作者完全的
-
University of California, DavisUnited States Department of Defense招聘中
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)终止
-
Aadi Bioscience, Inc.批准上市TSC1 | TSC2 | PEComa,恶性 | mTOR 通路畸变
-
Hillhurst Biopharmaceuticals, Inc.National Heart, Lung, and Blood Institute (NHLBI)完全的
-
Mayo ClinicNational Cancer Institute (NCI)完全的复发性卵巢癌 | 复发性头颈癌 | 复发性肾细胞癌 | III期肾细胞癌 | 子宫内膜癌 | III期膀胱癌 | 宫颈鳞状细胞癌 | IV 期乳腺癌 | 恶性子宫肿瘤 | 复发性膀胱癌 | 复发性乳腺癌 | 复发性宫颈癌 | 复发性前列腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | III期前列腺癌 | IV 期肾细胞癌 | IIIC期乳腺癌 | IV 期前列腺癌 | 晚期恶性肿瘤 | 复发性恶性肿瘤 | IIIA期卵巢癌 | IIIB期卵巢癌 | IIIC 期卵巢癌 | IV 期卵巢癌 | IVA 期宫颈癌 | IVB 期宫颈癌 | 实体肿瘤 | IIIA期宫颈癌 | IIIB 期宫颈癌 | IVA 期膀胱癌 | IVB 期膀胱癌美国
-
Sarcoma Oncology Research Center, LLCAadi Bioscience, Inc.完全的黑色素瘤 | 肾细胞癌 | 肝细胞癌 | 大肠癌 | 尤文肉瘤 | 非小细胞肺癌 | 脊索瘤 | 尿路上皮癌 | 经典霍奇金淋巴瘤 | PEComa | 硬纤维瘤 | 上皮样肉瘤 | 鳞状细胞癌 | MTOR激活突变美国
-
Assembly Biosciences完全的
-
Aadi Bioscience, Inc.National Cancer Institute (NCI)完全的
-
CelgeneUniversity of Arizona完全的
-
Chinese PLA General Hospital未知
-
University of Michigan Rogel Cancer CenterCelgene Corporation终止
-
University of WashingtonNational Cancer Institute (NCI); Celgene Corporation完全的
-
Emory UniversityNational Cancer Institute (NCI); Prostate Cancer Foundation招聘中
-
Selayang Hospital完全的
-
Mayo ClinicNational Cancer Institute (NCI)撤销
-
University of Alabama at BirminghamSusan G. Komen Breast Cancer Foundation; Daiichi Sankyo UK Ltd.; Triple Negative Breast Cancer...完全的
-
City of Hope Medical CenterNational Cancer Institute (NCI)主动,不招人复发性乳腺癌 | IV 期乳腺癌 AJCC v6 和 v7 | III 期乳腺癌 AJCC v7 | IIIA 期乳腺癌 AJCC v7 | IIIB 期乳腺癌 AJCC v7 | IIIC 期乳腺癌 AJCC v7 | 转移性乳腺癌 | 局部晚期乳腺癌美国
-
Aadi Bioscience, Inc.招聘中